These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11202192)

  • 1. [Chemobiokinetics of sarcolysin and its peptides with glutaminic acid].
    Mironiuk TA; Korsakov MV; Reztsova VV; Kon'kov SA; Zhdanova EA; Krasnov VP; Filov VA
    Vopr Onkol; 2000; 46(5):583-7. PubMed ID: 11202192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model.
    Glehen O; Stuart OA; Mohamed F; Sugarbaker PH
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):79-84. PubMed ID: 15048586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and phase II study of heated intraoperative intraperitoneal melphalan.
    Sugarbaker PH; Stuart OA
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):151-5. PubMed ID: 17091250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The participation of the adrenal catecholamine system of tumor-bearing rats in sarcolysin-mediated effect].
    Strigun LM; Konovalova NP
    Vopr Onkol; 1980; 26(6):54-9. PubMed ID: 7385730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of [14C] BBR 3053, an alkylating bisphosphonate, after single i.v. and multiple s.c. administration in rats.
    Bernareggi A; Crippa MT; Bastrup U; Di Giovine S; Cesarini R; Tognella S
    Boll Chim Farm; 1997 Apr; 136(4):304-7. PubMed ID: 9281891
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and in vivo biodisposition of [14C]-quaternary ammonium-melphalan conjugate, a potential cartilage-targeted alkylating drug.
    Rapp M; Giraud I; Maurizis JC; Galmier MJ; Madelmont JC
    Bioconjug Chem; 2003; 14(2):500-6. PubMed ID: 12643763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of isolated lung perfusion with melphalan for resectable pulmonary metastases, a phase I and extension trial.
    Grootenboers MJ; Hendriks JM; van Boven WJ; Knibbe CA; van Putte B; Stockman B; De Bruijn E; Vermorken JB; Van Schil PE; Schramel FM
    J Surg Oncol; 2007 Dec; 96(7):583-9. PubMed ID: 17999399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Disorders of blood rheology in Walker's carcinosarcoma-256 and in cyclophosphamide treatment of rats].
    Plotnikov MB; Maslov MIu; Aliev OI; Vasil'ev AS; Zueva EP; Krylova SG; Shilova NV
    Vopr Onkol; 2001; 47(3):335-7. PubMed ID: 11544834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADME investigations of unnatural peptides: distribution of a 14C-labeled beta 3-octaarginine in rats.
    Weiss HM; Wirz B; Schweitzer A; Amstutz R; Rodriguez Perez MI; Andres H; Metz Y; Gardiner J; Seebach D
    Chem Biodivers; 2007 Jul; 4(7):1413-37. PubMed ID: 17638323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Attempted sarcolysin therapy of pulmonary metastases of Walker's carcinosarcome].
    KISELEVA NS
    Patol Fiziol Eksp Ter; 1962; 6():50-3. PubMed ID: 14033068
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduced liver uptake of arterially infused melphalan during retrograde rat liver perfusion with unaffected liver tumor uptake.
    Rothbarth J; Sparidans RW; Beijnen JH; Schultze-Kool LJ; Putter H; van de Velde CJ; Mulder GJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):736-40. PubMed ID: 12388659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional differences of melphalan lung levels after isolated lung perfusion in the rat.
    Romijn S; Hendriks JM; Van Putte BP; Weyler J; Guetens G; De Boeck G; Van Schil PE
    J Surg Res; 2005 May; 125(2):157-60. PubMed ID: 15854668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of melphalan, infused over a 24-hour period, in patients with advanced malignancies.
    Mougenot P; Pinguet F; Fabbro M; Culine S; Poujol S; Astre C; Bressolle F
    Cancer Chemother Pharmacol; 2004 Jun; 53(6):503-12. PubMed ID: 15007638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, distribution and excretion of 14C-levofloxacin after single oral administration in albino and pigmented rats: binding characteristics of levofloxacin-related radioactivity to melanin in vivo.
    Tanaka M; Ono C; Yamada M
    J Pharm Pharmacol; 2004 Apr; 56(4):463-9. PubMed ID: 15099441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of methotrexate on perfusion and nitrogen-13 glutamate uptake in the Walker-256 carcinosarcoma.
    Knapp WH; Panzer M; Helus F; Layer K; Sinn HJ; Ostertag H
    J Nucl Med; 1988 Feb; 29(2):208-16. PubMed ID: 2894416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of (7alpha)-21-[4-[(diethylamino) methyl]-2-methoxyphenoxy]-7-methyl-19-norpregna-1,3,5(10)-trien-3-ol-20-[14C]2-hydroxy-1,2,3-propanetricarboxylate ([14C]TAS-108) and its metabolites after single oral administration to rats bearing 7,12-dimethylbenz(alpha)anthracene-induced mammary tumor.
    Yamaya H; Saeki M; Yoshida K; Shibata J; Yano S; Sato Y; Takao A; Shindo T; Buzdar AU; Nagayama S
    Drug Metab Dispos; 2006 Feb; 34(2):331-8. PubMed ID: 16299166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aminazine distribution in the organs and tissues of rats depending on the routes of administration and the age of the animals].
    Uzbekova DG
    Farmakol Toksikol; 1979; 42(4):354-8. PubMed ID: 477954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro cytotoxic effect of melphalan and pilot phase II study in hormone-refractory prostate cancer.
    Mougenot P; Bressolle F; Culine S; Solassol I; Poujol S; Pinguet F
    Anticancer Res; 2006; 26(3B):2197-203. PubMed ID: 16821586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.